Results 101 to 110 of about 1,973 (178)

Effect of switching from sevelamer hydrochloride to lanthanum carbonate on metabolic acidosis in dialysis patients

Treatments for hyperphosphatemia in dialysis patients include dietary therapy and oral administration of phosphate binders; however, it has recently been suggested that oral administration of sevelamer hydrochloride, a phosphate binder, may cause ...
Uramatsu, Tadashi, Nishino, Tomoya, Hirose, Misaki, Funakoshi, Satoshi, Kohno, Shigeru, Harada, Takashi, Minami, Kana, Arai, Hideyuki, Obata, Yoko, Yamashita, Hiroshi   +9 more
core  

Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study.

Nephron, 2020
Covic AC, Sprague SM, Rastogi A, Ketteler M, Walpen S, Perrin A, Floege J.   +6 more
europepmc   +1 more source

EFFECTS OF CALCIUM CARBONATE AND SEVELAMER ON EVENTS IN PATIENTS WITH CKD NOT ON DIALYSIS. THE INDEPENDENT-CKD STUDY

, 2011
Introduction. Coronary artery calcifications reflect the atherosclerotic disease burden and are strongly associated to events in all stages of CKD. There is no study showing that a reduction of coronary artery calcifications may improve events rate in ...
Di Iorio, B., Bellasi, A., RUSSO, DOMENICO, Torraca, S., Di Micco, L., Sirico, M. L.   +5 more
core  

Sevelamer Carbonate and Lanthanum Usage Evaluation and Cost Considerations at a Veteran's Affairs Medical Center. [PDF]

Hosp Pharm, 2016
Robison R, Cooney D, Low MB, Desai N.
europepmc   +1 more source

Sevelamer carbonate reduces the risk of hypomagnesemia in hemodialysis-requiring end-stage renal disease patients. [PDF]

Clin Kidney J, 2016
Rosa-Diez G, Negri AL, Crucelegui MS, Philippi R, Perez-Teysseyre H, Sarabia-Reyes C, Loor-Navarrete H, Heguilen R.   +7 more
europepmc   +1 more source

Uso do cloridrato de sevelamer e carbonato de cálcio na hiperfosfatemia de pacientes em hemodiálise

, 2009
To evaluate the effectiveness of sevelamer and calcium carbonate as phosphate binder. METHODS: We selected 31 patients (55±14 years) who underwent haemodyalisis (HD) 3 times / week 4 h / session, which were raised test results in zero time and end time ...
de Deus, Rogério Barbosa, Malagutti, William, Ferraz, Renato Ribeiro Nogueira   +2 more
core  

Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease. [PDF]

Clin J Am Soc Nephrol, 2015
Yubero-Serrano EM, Woodward M, Poretsky L, Vlassara H, Striker GE, AGE-less Study Group.   +5 more
europepmc   +1 more source

Comparison of the effects of non-calcium and calcium-based phosphate binders on fibroblast growth factor-23 levels in patients with CKD-mineral and bone disorder: a meta-analysis of randomized controlled trials. [PDF]

BMC Nephrol
Cha S, Baek M, Jung C, Kim H.
europepmc   +1 more source

Phosphate-latest news and ongoing trials. [PDF]

Clin Kidney J
Parpia AS, Kumra R, Mansell C, Harel Z, Perl J, Ben-Bassat OK, Wald R.   +6 more
europepmc   +1 more source

Assessing the real-world drug safety of sevelamer for hyperphosphatemia: Insights from a comprehensive analysis of the FDA adverse event reporting system (FAERS) database. [PDF]

Medicine (Baltimore)
Shao X, Yang H, Tan C, Liu J, Zhou L.
europepmc   +1 more source